MedPath

KeyBioscience AG

🇨🇭Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:4
Completed:1

Trial Phases

2 Phases

Phase 1:5
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 2
2 (28.6%)

Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis

Phase 2
Recruiting
Conditions
Osteoarthritis in the Knee
Obesity
Interventions
Drug: Placebo
First Posted Date
2025-02-19
Last Posted Date
2025-02-19
Lead Sponsor
KeyBioscience AG
Target Recruit Count
600
Registration Number
NCT06833749
Locations
🇨🇿

Pratia Brno, s.r.o, Brno, Czech Republic

🇨🇿

L.K.N. Artrocentrum, Hlučín, Czech Republic

🇨🇿

Medical Plus, s.r.o, Hradiště, Czech Republic

and more 17 locations

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Phase 1
Terminated
Conditions
Type II Diabetes Mellitus
Interventions
Drug: Daily injection of KBP/placebo for up to 28 days
First Posted Date
2019-04-08
Last Posted Date
2020-09-03
Lead Sponsor
KeyBioscience AG
Target Recruit Count
25
Registration Number
NCT03907202
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes

Phase 2
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Daily injection of KBP/placebo for 12 weeks as add-on to metformin
First Posted Date
2017-07-26
Last Posted Date
2018-09-11
Lead Sponsor
KeyBioscience AG
Target Recruit Count
255
Registration Number
NCT03230786
Locations
🇨🇿

Vdoviak Miroslav MUDr. - Interní Ambulance, Karlovy Vary, Czechia

🇨🇿

General University Hospital, Prague 2, Czechia

🇨🇿

Institute for Clinical and experimental Medicine, Praha 4, Czechia

and more 25 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.